glp 1 menopause weight gain Semaglutide and Menopause: Does It Work? Weight, Estrogen & GLP-1 Plateaus

Clin Biochem 2002

Currently, there is an ongoing randomised double-masked placebo-controlled trial, the SUMMIT trial, studying the efficacy and safety of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and GLP-1 receptors, versus placebo in HFpEF patients with obesity (NCT04847557)

Does not contain: Parabens, sulfates, perfumes, mineral oil, artificial preservatives and colours, gluten or dairy

Oxidative damage in ischemic stroke revealed using multiple biomarkers

The above results suggest that different doses, frequency of administration, or method of administration of capsaicin may be the reasons for the differences in conclusions